Fifth Third Bancorp Raises Stock Holdings in Cigna Group $CI

Fifth Third Bancorp increased its stake in shares of Cigna Group (NYSE:CI) by 211.9% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 76,660 shares of the health services provider’s stock after purchasing an additional 52,078 shares during the period. Fifth Third Bancorp’s holdings in Cigna Group were worth $20,449,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CI. Vanguard Group Inc. lifted its holdings in shares of Cigna Group by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after buying an additional 414,834 shares during the period. State Street Corp grew its holdings in shares of Cigna Group by 1.8% in the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock worth $3,396,132,000 after acquiring an additional 224,122 shares during the period. Massachusetts Financial Services Co. MA increased its position in Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock valued at $3,249,113,000 after acquiring an additional 903,334 shares during the last quarter. Dodge & Cox increased its position in Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after acquiring an additional 1,833,389 shares during the last quarter. Finally, GQG Partners LLC lifted its holdings in Cigna Group by 14.3% in the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock valued at $2,136,699,000 after acquiring an additional 972,302 shares during the period. Institutional investors own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CI. Jefferies Financial Group lowered their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research note on Monday, April 20th. Raymond James Financial set a $340.00 target price on shares of Cigna Group in a research note on Friday, May 1st. Morgan Stanley upped their target price on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Royal Bank Of Canada increased their price target on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research note on Friday, May 1st. Finally, UBS Group boosted their price objective on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $338.80.

Cigna Group Price Performance

CI stock opened at $304.60 on Tuesday. The firm has a market capitalization of $80.57 billion, a P/E ratio of 12.91, a price-to-earnings-growth ratio of 1.13 and a beta of 0.29. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a fifty day simple moving average of $285.95 and a two-hundred day simple moving average of $279.98.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. During the same period in the prior year, the company posted $6.74 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were given a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is 26.45%.

Insider Activity

In other news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.